About CMAX
CMAX is a company based in Adelaide (Australia) founded in 1993 was acquired by I'Rom Group in October 2016. It operates as a Professional Services. CMAX offers products and services including Clinical Trials.
- Headquarter Adelaide, Australia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
I'Rom Group
(Oct 28, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CMAX
CMAX offers a comprehensive portfolio of products and services, including Clinical Trials.
Clinical trials are conducted for medical advancements globally.
Funding Insights of CMAX
Detailed funding history for CMAX
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CMAX
CMAX has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include I'Rom Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Japanese clinical research enabler and providing site management office services
|
Locked | Locked | Locked |
Investor details for CMAX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CMAX
Investment portfolio details for CMAX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CMAX
Detailed financials for CMAX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cmax Comparisons
Peer comparison for CMAX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CMAX
Detailed competitors of CMAX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cmax
Complete news archive for CMAX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CMAX
CMAX was founded in 1993.
CMAX is headquartered in Adelaide, Australia. It is registered at Adelaide, South Australia, Australia.
CMAX is established as one of Australias most experienced clinical trial centers, based in Adelaide. Early-phase clinical trials are conducted in partnership with pharmaceutical, biotechnology, and device companies. Since 1993, over 600 trials, including more than 100 first-time-in-human studies, have been delivered. The facility, opened in 2016, is located adjacent to the Royal Adelaide Hospital in the Bio-Med City precinct. State-of-the-art equipment and access to world-class medical specialists are provided. Solutions span cancer treatments, bio-devices, and hormone therapies, contributing to global medical advancements.
CMAX offers Clinical Trials.
CMAX has 1 investor. Key investors include I'Rom Group.